• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Med Genet. Dec 1999; 36(12): 873–880.
PMCID: PMC1734270

Familial gastric cancer: overview and guidelines for management*


Families with autosomal dominant inherited predisposition to gastric cancer have been described. More recently, germline E-cadherin/CDH1 mutations have been identified in hereditary diffuse gastric cancer kindred. The need to have protocols to manage and counsel these families in the clinic led a group of geneticists, gastroenterologists, surgeons, oncologists, pathologists, and molecular biologists to convene a workshop to produce consensus statements and guidelines for familial gastric cancer. Review of the available cancer pathology from people belonging to families with documented germline E-cadherin/CDH1 mutations confirmed that the gastric cancers were all of the diffuse type. Criteria to define the different types of familial gastric cancer syndromes were agreed. Foremost among these criteria was that review of histopathology should be part of the evaluation of any family with aggregation of gastric cancer cases. Guidelines for genetic testing and counselling in hereditary diffuse gastric cancer were produced. Finally, a proposed strategy for clinical management in families with high penetrance autosomal dominant predisposition to gastric cancer was defined.

Keywords: gastric cancer; familial; hereditary; E-cadherin

Full Text

The Full Text of this article is available as a PDF (100K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abulrahi HA, Bohlega EA, Fontaine RE, al-Seghayer SM, al-Ruwais AA. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet. 1997 Jan 4;349(9044):23–25. [PubMed]
  • Correa P, Chen VW. Gastric cancer. Cancer Surv. 1994;19-20:55–76. [PubMed]
  • Bonney GE, Elston RC, Correa P, Haenszel W, Zavala DE, Zarama G, Collazos T, Cuello C. Genetic etiology of gastric carcinoma: I. Chronic atrophic gastritis. Genet Epidemiol. 1986;3(4):213–224. [PubMed]
  • JONES EG. FAMILIAL GASTRIC CANCER. N Z Med J. 1964 May;63:287–296. [PubMed]
  • Seruca R, Carneiro F, Castedo S, David L, Lopes C, Sobrinho-Simões M. Familial gastric polyposis revisited. Autosomal dominant inheritance confirmed. Cancer Genet Cytogenet. 1991 May;53(1):97–100. [PubMed]
  • Shafiuddin M, Caminker M, Batra S. Hereditary linitis plastica of the stomach. Am J Gastroenterol. 1995 Nov;90(11):2062–2063. [PubMed]
  • Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature. 1998 Mar 26;392(6674):402–405. [PubMed]
  • Carneiro F, Seixas M, Sobrinho-Simões M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract. 1995 Jul;191(6):571–584. [PubMed]
  • Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N, Berx G, Sobrinho-Simões M. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest. 1999 Apr;79(4):459–465. [PubMed]
  • Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994 Jul 15;54(14):3845–3852. [PubMed]
  • Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res. 1996 Nov;87(11):1153–1159. [PubMed]
  • Muta H, Noguchi M, Kanai Y, Ochiai A, Nawata H, Hirohashi S. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res. 1996 Aug;87(8):843–848. [PubMed]
  • Carneiro F, Santos L, David L, Dabelsteen E, Clausen H, Sobrinho-Simões M. T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma. Histopathology. 1994 Feb;24(2):105–113. [PubMed]
  • Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, Fraumeni JF, Jr, Buiatti E. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):15–18. [PubMed]
  • Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998 Sep 15;58(18):4086–4089. [PubMed]
  • Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999 Apr;8(4):607–610. [PubMed]
  • Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14(3):249–255. [PubMed]
  • Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, Grundei T, Becker KF, Mueller J, Siewert JR, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999 Aug;155(2):337–342. [PMC free article] [PubMed]
  • Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis. 1999 Jun;20(6):1127–1131. [PubMed]
  • Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet. 1999;44(3):177–180. [PubMed]
  • Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, Nagengast FM, Meijers-Heijboer EH, Bertario L, Varesco L, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996 Apr;110(4):1020–1027. [PubMed]
  • Aarnio M, Salovaara R, Aaltonen LA, Mecklin JP, Järvinen HJ. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer. 1997 Oct 21;74(5):551–555. [PubMed]
  • Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst. 1998 Jul 15;90(14):1039–1071. [PubMed]
  • Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD, Santibanez-Koref MF, Martin J, Birch JM, Evans DG. An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet. 1995 Dec;32(12):942–945. [PMC free article] [PubMed]
  • Lynch HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer. 1971 Jun;27(6):1505–1511. [PubMed]
  • La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer. 1992 Jul 1;70(1):50–55. [PubMed]
  • Berx G, Becker KF, Höfler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;12(4):226–237. [PubMed]
  • Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg. 1993 Nov;218(5):583–592. [PMC free article] [PubMed]
  • Yoshida S, Saito D. Gastric premalignancy and cancer screening in high-risk patients. Am J Gastroenterol. 1996 May;91(5):839–843. [PubMed]
  • Stepp H, Sroka R, Baumgartner R. Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques, and clinical experience. Endoscopy. 1998 May;30(4):379–386. [PubMed]
  • Fennerty MB. Should chromoscopy be part of the "proficient" endoscopist's armamentarium? Gastrointest Endosc. 1998 Mar;47(3):313–315. [PubMed]
  • Miholic J, Meyer HJ, Kotzerke J, Balks J, Aebert H, Jähne J, Weimann A, Pichlmayr R. Emptying of the gastric substitute after total gastrectomy. Jejunal interposition versus Roux-y esophagojejunostomy. Ann Surg. 1989 Aug;210(2):165–172. [PMC free article] [PubMed]
  • Miholic J, Meyer HJ, Müller MJ, Weimann A, Pichlmayr R. Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surgery. 1990 Sep;108(3):488–494. [PubMed]
  • Cuschieri A. Jejunal pouch reconstruction after total gastrectomy for cancer: experience in 29 patients. Br J Surg. 1990 Apr;77(4):421–424. [PubMed]
  • Svedlund J, Sullivan M, Liedman B, Lundell L, Sjödin I. Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg. 1997 May;21(4):422–433. [PubMed]
  • Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L. Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997 May;21(4):416–421. [PubMed]
  • Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 1995 Dec 15;14(24):6107–6115. [PMC free article] [PubMed]
  • Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999 Jun;116(6):1453–1456. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • OMIM
    OMIM record citing PubMed
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...